Human VEGF165 Antibody

R&D Systems | Catalog # AB-293-NA

R&D Systems
Loading...

Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human, Mouse, Rat, Primate - Macaca mulatta (Rhesus Macaque), Rabbit, Xenograft

Applications

Validated:

Immunohistochemistry, Western Blot, Neutralization

Cited:

Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot, Neutralization, Bioassay, Complex Application, ELISA Development

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG
Loading...

Product Specifications

Immunogen

S. frugiperda insect ovarian cell line Sf 21-derived recombinant human VEGF165
Ala27-Arg191
Accession # AAV38412

Specificity

Detects human VEGF

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Endotoxin Level

<0.10 EU per 1 μg of the antibody by the LAL method.

Scientific Data Images for Human VEGF165 Antibody

VEGF165in Human Breast Cancer Tissue.

VEGF165in Human Breast Cancer Tissue.

VEGF165was detected in immersion fixed frozen sections of human breast cancer tissue using 5 µg/mL Human VEGF165Polyclonal Antibody (Catalog # AB‑293‑NA) overnight at 4 °C. Tissue was stained (red) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Frozen Tissue Sections.
Cell Proliferation Induced by VEGF165and Neutralization by Human VEGF Antibody.

Cell Proliferation Induced by VEGF165and Neutralization by Human VEGF Antibody.

Recombinant Human VEGF165(Catalog # 293-VE) stimulates proliferation in HUVEC human umbilical vein endothelial cells in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human VEGF165(10 ng/mL) is neutralized (green line) by increasing concentrations of Human VEGF 165 Polyclonal Antibody (Catalog # AB-293-NA). The ND50 is typically 0.600-7.20 µg/mL.
VEGF antibody in Human Breast Cancer Tissue by Immunohistochemistry (IHC-P).

VEGF in Human Breast Cancer Tissue.

VEGF was detected in immersion fixed paraffin-embedded sections of human breast cancer tissue using Human VEGF 165 Polyclonal Antibody (Catalog # AB-293-NA) at 15 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). Lower panel shows a lack of labeling if primary antibodies are omitted and tissue is stained only with secondary antibody followed by incubation with detection reagents. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
Detection of VEGF165 by Immunohistochemistry

Detection of VEGF165 by Immunohistochemistry

The intracellular relocation of PHB was induced by vascular endothelial growth factor (VEGF) in CRC (A) Stromal were mixed with LS174T or SW480 or SW620 & were cultured for 24 h. Supernatants were collected & VEGF levels were determined using the enzyme-linked immune sorbent assay (ELISA). *P < 0.01, **P < 0.001. Data are shown as means ± SD. Levels of VEGF expression in the interstitial tissue are shown in primary CRC with metastasis & non-metastasis. *P < 0.001. Data are shown as means ± SEM. (B) Quantitative analysis of wound-healing assays was performed by calculating the percentage of in which PHB was relocated to the direction of wound. *P < 0.01 & **P < 0.001. Data are shown as means ± SD. (C) A schematic model & an experimental example for the polarized migration assay. A mixture of VEGF & Matrigel was placed in area 1, Matrigel alone was placed in area 2, 3, & 4, & the in area 5 were chosen for polarization analysis. in which PHB was located within the 120° angle were counted as being in the direction of VEGF stimulation, & are marked as red stars. The quantitative analysis of polarity assays was performed by calculation of the percentage of in which PHB was relocated to the direction of VEGF stimulation. *P < 0.001 compared with VEGF treatment for 0 h. Data are shown as means ± SD. (D) Co-immunoprecipitation assay with Cdc42. Cdc42 & PHB were expressed in SW480/LS174T with (+) or without (-) VEGF (100 ng/mL) treatment for 24 h. (E) Indicated GST-fusion proteins were incubated with lysates from SW480/LS174T & precipitated with glutathione beads. PHB was detected in the eluates of GST-Cdc42. (F) Co-immunostaining for PHB & Cdc42 in SW480/LS174T with or without VEGF stimulation. The arrowheads indicate PHB & Cdc42 directionality. Scale bars: 10 μm. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/29100316), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human VEGF165 Antibody

Application
Recommended Usage

Immunohistochemistry

5-15 µg/mL
Sample: Immersion fixed frozen or paraffin-embedded sections of human breast cancer tissue

Western Blot

1 µg/mL
Sample: Recombinant Human VEGF165 (Catalog # 293-VE)

Neutralization

Measured by its ability to neutralize VEGF165-induced proliferation in HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci USA 87:1323. The Neutralization Dose (ND50) is typically 0.600-7.20 µg/mL in the presence of 10 ng/mL Recombinant Human VEGF165.

Formulation, Preparation, and Storage

Purification

Protein A or G purified

Reconstitution

Reconstitute at 1 mg/mL in sterile PBS.


Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: VEGF

Vascular Endothelial Growth Factor (VEGF or VEGF-A), also known as Vascular Permeability Factor (VPF), is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the PDGF family that is characterized by the presence of eight conserved cysteine residues and a cystine knot structure. VEGF165 appears to be the most abundant and potent isoform, followed by VEGF121 and VEGF189. Human VEGF165 is an approximately 44 kDa molecular weight homodimer sharing 88% aa sequence identity with corresponding regions of mouse and rat, 96% with porcine, 95% with canine, and 93% with feline, equine and bovine VEGF, respectively. VEGF binds the type I transmembrane receptor tyrosine kinases VEGF R1 (also called Flt-1) and VEGF R2 (Flk-1/KDR) on endothelial cells. Although VEGF affinity is highest for binding to VEGF R1, VEGF R2 appears to be the primary mediator of VEGF angiogenic activity. VEGF165 binds the Semaphorin receptor, Neuropilin-1 and promotes complex formation with VEGF R2. VEGF is required during embryogenesis and functions to regulate the proliferation, migration, and survival of endothelial cells. In adults, VEGF functions mainly in wound healing and the female reproductive cycle. Pathologically, it is involved in tumor angiogenesis and vascular leakage. Circulating VEGF levels correlate with disease activity in autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus. VEGF is induced by hypoxia and cytokines such as IL-1, IL-6, IL-8, Oncostatin M (OSM) and TNF-alpha.

Long Name

Vascular Endothelial Growth Factor

Alternate Names

MVCD1, VAS, Vasculotropin, VEGF-A, VEGFA, VPF

Entrez Gene IDs

7422 (Human); 22339 (Mouse); 83785 (Rat); 281572 (Bovine); 403802 (Canine); 493845 (Feline); 30682 (Zebrafish)

Gene Symbol

VEGFA

UniProt

Additional VEGF Products

Product Documents for Human VEGF165 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human VEGF165 Antibody

For research use only

Citations for Human VEGF165 Antibody

Customer Reviews for Human VEGF165 Antibody

There are currently no reviews for this product. Be the first to review Human VEGF165 Antibody and earn rewards!

Have you used Human VEGF165 Antibody?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies